US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NovaBridge Biosciences

2.00

+0.09004.71%

Post-market: 2.010.0100+0.50%19:46 EDT

Volume:443.03K

Turnover:875.90K

Market Cap:230.53M

PE:-4.14

High:2.02

Open:1.91

Low:1.89

Close:1.91

52wk High:6.79

52wk Low:1.46

Shares:115.27M

Float Shares:64.21M

Volume Ratio:1.46

T/O Rate:0.69%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4830

EPS(LYR):-0.9225

ROE:-59.10%

ROA:-34.98%

PB:1.15

PE(LYR):-2.17

Loading ...

Overview Company News Filings

NovaBridge Biosciences Price Target Maintained with a $9.00/Share by HC Wainwright & Co.

NovaBridge Net Loss Widens to $37.9 Million in FY26 First Half; R&D Expenses More than Doubled to $14.3 Million

NovaBridge Biosciences H1 EPS $(0.33) Misses $(0.14) Estimate

Benzinga Earnings

Novabridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution

THOMSON REUTERS

NovaBridge Biosciences Expected to Post a Loss of 13 Cents a Share - Earnings Preview

NovaBridge Biosciences Expected to Post a Loss of 13 Cents a Share - Earnings Preview

NovaBridge Biosciences Schedules Webcast for First-Half 2026 Results, Corporate Update

Novabridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026

THOMSON REUTERS

Village Farms International And 2 Other Penny Stocks Worth Watching

Simply Wall St.

Press Release: Novabridge Biosciences to Hold Annual General Meeting on September 8, 2026

Novabridge Biosciences Launches 2026 Omnibus Share Incentive Plan with 11,960,000 Shares Authorized

Poland’s central bank is buying the dip as gold's biggest buyers aren't backing down

Novabridge Biosciences CEO, Director Srishti Gupta Files Initial Beneficial Ownership Statement

Novabridge Biosciences SVP Clinical Development Xu Cong Claire Sells USD 3,991 Common Shares

Novabridge Biosciences Appoints DR. Srishti Gupta as Chief Executive Officer

THOMSON REUTERS

Novabridge Biosciences - Xi-yong (sean) Fu to Step Down as CEO and Support in Advisory Capacity

THOMSON REUTERS

Press Release: Novabridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

Wuxi XDC Appoints Yuan Fang Joint Company Secretary, Authorized Representative

NovaBridge Biosciences CMO Dennis Phillip Andrew disposes of ordinary shares worth $5,606.04

NovaBridge Biosciences replaces PwC with Deloitte as auditor

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NBP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBP\",,,,,undefined,":{"symbol":"NBP","market":"US","secType":"STK","nameCN":"NovaBridge Biosciences","latestPrice":2,"timestamp":1787342400000,"preClose":1.91,"halted":0,"volume":443031,"hourTrading":{"tag":"盘后","latestPrice":2.01,"preClose":2,"latestTime":"19:46 EDT","volume":877,"amount":1748.9,"timestamp":1787356001071,"change":0.01,"changeRate":0.005,"amplitude":0.01},"delay":0,"changeRate":0.04712041884816758,"floatShares":64212900,"shares":115266053,"eps":-0.483,"marketStatus":"Market Closed","change":0.09,"latestTime":"08-21 16:00:00 EDT","open":1.91,"high":2.02,"low":1.889,"amount":875899.8435281999,"amplitude":0.068586,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.483,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":2.3,"listingDate":1579237200000,"exchange":"NASDAQ","adjPreClose":1.91,"preHourTrading":{"tag":"盘前","latestPrice":1.95,"preClose":1.91,"latestTime":"09:15 EDT","volume":4169,"amount":7804.1324515,"timestamp":1787318100261,"change":0.04,"changeRate":0.020942,"amplitude":0.041885},"postHourTrading":{"tag":"盘后","latestPrice":2.01,"preClose":2,"latestTime":"19:46 EDT","volume":877,"amount":1748.9,"timestamp":1787356001071,"change":0.01,"changeRate":0.005,"amplitude":0.01},"volumeRatio":1.4636051748026337,"impliedVol":1.8929,"impliedVolPercentile":0.7635},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBP\",,,,,undefined,":{"symbol":"NBP","floatShares":64212900,"roa":"-34.98%","roe":"-59.10%","lyrEps":-0.922468,"volumeRatio":1.4636051748026337,"shares":115266053,"dividePrice":0,"high":2.02,"amplitude":0.068586,"preClose":1.91,"low":1.889,"week52Low":1.46,"pbRate":"1.15","week52High":6.79,"institutionHeld":0,"latestPrice":2,"eps":-0.483,"divideRate":0,"volume":443031,"delay":0,"ttmEps":-0.483,"open":1.91,"prevYearClose":3.98,"prevWeekClose":1.96,"prevMonthClose":1.6,"prevQuarterClose":1.95,"fiveDayClose":1.96,"twentyDayClose":1.77,"sixtyDayClose":1.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBP\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"NBP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787212800000,"name":null,"time":"Pre-MKt","dateTimestamp":1787198400000,"actualEps":null},{"market":"US","date":"2026-04-07","symbol":"NBP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1775534400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-20","symbol":"NBP","fiscalQuarterEnding":"2025/06","expectedEps":-0.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-05-15","symbol":"NBP","fiscalQuarterEnding":"2025/03","expectedEps":-0.07,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.04},{"market":"US","date":"2025-04-03","symbol":"NBP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1743652800000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1759550400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBP","date":"2026-08-21","current":-4.140787,"percent":1,"low":-20.276437,"twenty":-14.583269,"median":-11.035987,"eighty":-2.356433,"high":-1.87904,"avg":-8.685292,"sd":6.054305,"marketCap":220888642},"quantilePoints":[{"date":"2025-10-31","current":-13.114792,"twenty":-13.114792,"median":-13.114792,"eighty":-13.114792,"marketCap":524460541},{"date":"2025-11-07","current":-12.077138,"twenty":-13.547148,"median":-12.71126,"eighty":-12.278904,"marketCap":482964762},{"date":"2025-11-14","current":-12.019491,"twenty":-13.114792,"median":-12.278904,"eighty":-12.077138,"marketCap":480659441},{"date":"2025-11-21","current":-12.077138,"twenty":-13.085968,"median":-12.293316,"eighty":-12.077138,"marketCap":482964762},{"date":"2025-11-28","current":-11.068308,"twenty":-13.06291,"median":-12.192433,"eighty":-11.881137,"marketCap":442621643},{"date":"2025-12-05","current":-11.500664,"twenty":-12.688201,"median":-12.077138,"eighty":-11.212426,"marketCap":459911551},{"date":"2025-12-12","current":-11.298898,"twenty":-12.411494,"median":-12.033903,"eighty":-11.287368,"marketCap":451842927},{"date":"2025-12-19","current":-17.342266,"twenty":-12.688201,"median":-12.048315,"eighty":-11.460311,"marketCap":456552482},{"date":"2025-12-26","current":-20.276437,"twenty":-13.287734,"median":-12.077138,"eighty":-11.500664,"marketCap":533797473},{"date":"2026-01-02","current":-17.429853,"twenty":-17.342266,"median":-12.163609,"eighty":-11.512194,"marketCap":458858303},{"date":"2026-01-09","current":-16.597774,"twenty":-17.482405,"median":-12.235668,"eighty":-11.541017,"marketCap":436953007},{"date":"2026-01-16","current":-16.028458,"twenty":-17.394818,"median":-12.365376,"eighty":-11.569841,"marketCap":421965173},{"date":"2026-01-23","current":-17.03571,"twenty":-17.342266,"median":-13.057145,"eighty":-11.587135,"marketCap":448482110},{"date":"2026-01-30","current":-16.116045,"twenty":-17.3773,"median":-13.33097,"eighty":-11.615959,"marketCap":424270994},{"date":"2026-02-06","current":-14.583269,"twenty":-17.342266,"median":-14.495682,"eighty":-11.742783,"marketCap":383919133},{"date":"2026-02-13","current":-14.189126,"twenty":-17.307231,"median":-14.71465,"eighty":-11.823489,"marketCap":373542940},{"date":"2026-02-20","current":-14.539475,"twenty":-17.167091,"median":-14.517578,"eighty":-11.961843,"marketCap":382766222},{"date":"2026-02-27","current":-14.364301,"twenty":-17.03571,"median":-14.408094,"eighty":-12.019491,"marketCap":378154581},{"date":"2026-03-06","current":-15.94087,"twenty":-17.03571,"median":-14.386197,"eighty":-12.048315,"marketCap":419659352},{"date":"2026-03-13","current":-12.875318,"twenty":-16.991917,"median":-14.364301,"eighty":-12.077138,"marketCap":338955631},{"date":"2026-03-20","current":-11.780478,"twenty":-16.948123,"median":-14.316021,"eighty":-12.077138,"marketCap":310132873},{"date":"2026-03-27","current":-11.167368,"twenty":-16.597774,"median":-14.189126,"eighty":-11.788901,"marketCap":293992129},{"date":"2026-04-02","current":-10.773226,"twenty":-16.597774,"median":-14.101539,"eighty":-11.587135,"marketCap":283615936},{"date":"2026-04-10","current":-3.171352,"twenty":-16.387565,"median":-14.057746,"eighty":-11.527134,"marketCap":280157205},{"date":"2026-04-17","current":-3.495376,"twenty":-16.299978,"median":-13.61981,"eighty":-11.287368,"marketCap":308781505},{"date":"2026-04-24","current":-3.23355,"twenty":-16.221149,"median":-13.10038,"eighty":-11.118286,"marketCap":285651804},{"date":"2026-05-01","current":-3.23355,"twenty":-16.203632,"median":-12.875318,"eighty":-11.061844,"marketCap":285651804},{"date":"2026-05-08","current":-2.906268,"twenty":-16.133562,"median":-12.604261,"eighty":-10.634902,"marketCap":256739678},{"date":"2026-05-15","current":-2.513529,"twenty":-16.045975,"median":-12.365376,"eighty":-3.526795,"marketCap":222045127},{"date":"2026-05-22","current":-2.330251,"twenty":-15.993423,"median":-12.293316,"eighty":-3.374936,"marketCap":205854337},{"date":"2026-05-29","current":-2.448072,"twenty":-15.958388,"median":-12.192433,"eighty":-3.235384,"marketCap":216262702},{"date":"2026-06-05","current":-2.356433,"twenty":-15.651833,"median":-12.134786,"eighty":-3.190946,"marketCap":208167307},{"date":"2026-06-12","current":-1.92442,"twenty":-15.393451,"median":-12.062727,"eighty":-3.136675,"marketCap":170003300},{"date":"2026-06-18","current":-2.055333,"twenty":-15.340898,"median":-11.990667,"eighty":-3.100019,"marketCap":181568151},{"date":"2026-06-26","current":-2.094607,"twenty":-15.292725,"median":-11.780478,"eighty":-2.890558,"marketCap":185037606},{"date":"2026-07-02","current":-2.605168,"twenty":-15.231414,"median":-11.587135,"eighty":-2.686334,"marketCap":230140522},{"date":"2026-07-10","current":-2.434981,"twenty":-15.178862,"median":-11.559911,"eighty":-2.610404,"marketCap":215106217},{"date":"2026-07-17","current":-2.343342,"twenty":-15.091275,"median":-11.517717,"eighty":-2.516147,"marketCap":207010822},{"date":"2026-07-24","current":-2.317159,"twenty":-15.012446,"median":-11.399781,"eighty":-2.437599,"marketCap":204697852},{"date":"2026-07-31","current":-2.146972,"twenty":-14.977411,"median":-11.226206,"eighty":-2.42189,"marketCap":189663546},{"date":"2026-08-07","current":-2.22552,"twenty":-14.977411,"median":-11.123574,"eighty":-2.356433,"marketCap":196602456},{"date":"2026-08-14","current":-2.487346,"twenty":-14.84603,"median":-11.068308,"eighty":-2.356433,"marketCap":219732157},{"date":"2026-08-21","current":-1.87904,"twenty":-14.583269,"median":-11.035987,"eighty":-2.356433,"marketCap":220888642}],"updateTime":1787509060236},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661361822","title":"NovaBridge Biosciences Price Target Maintained with a $9.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661361822","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661361822?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:47","pubTimestamp":1787244420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NBP/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286568","title":"NovaBridge Net Loss Widens to $37.9 Million in FY26 First Half; R&D Expenses More than Doubled to $14.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286568","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286568?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:01","pubTimestamp":1787223706,"startTime":"0","endTime":"0","summary":"NovaBridge net loss widens to $37.9 million in FY26 first half; R&D expenses more than doubled to $14.3 millionNovaBridge posted a GAAP net loss of USD 37.9 million; loss per share widened to USD 0.14","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL7rbjbk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","NBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BQXX3F31.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU2095319765.USD","SG9999014005.SGD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210150020.SGD","BCDF","BK4112","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BN0W2V16.EUR","SG9999014021.USD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286580","title":"NovaBridge Biosciences H1 EPS $(0.33) Misses $(0.14) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286580","media":"Benzinga Earnings","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286580?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:01","pubTimestamp":1787223664,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences (NASDAQ:NBP) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.14) by 135.71 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61324048/novabridge-biosciences-h1-eps-0-33-misses-0-14-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660286356","title":"Novabridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286356?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:00","pubTimestamp":1787223603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUA9BZ5YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660446768","title":"NovaBridge Biosciences Expected to Post a Loss of 13 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2660446768","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660446768?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:44","pubTimestamp":1787057063,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences <NBP.OQ> expected to post a loss of13cents a share - Earnings PreviewNovaBridge BiosciencesNBP.OQNBP.Ois expected to  show no change in quarterly revenue when it reports  result","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL8N44F0P1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659414452","title":"NovaBridge Biosciences Expected to Post a Loss of 13 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2659414452","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659414452?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:08","pubTimestamp":1786712885,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences <NBP.OQ> expected to post a loss of13cents a share - Earnings PreviewNovaBridge BiosciencesNBP.OQNBP.Ois expected to  show no change in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B0V6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160107","title":"NovaBridge Biosciences Schedules Webcast for First-Half 2026 Results, Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160107","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160107?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:00","pubTimestamp":1786654857,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences schedules webcast for first-half 2026 results, corporate updateNovaBridge schedules a webcast on Aug. 20, 2026 to report first-half 2026 financial results and give a corporate u","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLbFBzTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK4585","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4112","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4139","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BKPKM429.USD","BCDF","SG9999014039.USD","NBP","SG9999014013.SGD","BK4588","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160123","title":"Novabridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160123?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:00","pubTimestamp":1786654842,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA9LM0YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658582949","title":"Village Farms International And 2 Other Penny Stocks Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2658582949","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658582949?lang=en_us&edition=fundamental","pubTime":"2026-08-11 01:05","pubTimestamp":1786381509,"startTime":"0","endTime":"0","summary":"The market has shown robust performance, with a 2.7% increase over the last week and a 21% rise in the past year, while earnings are expected to grow by 17% annually. In light of these conditions, investors may find value in exploring penny stocks—an older term that still signifies potential within smaller or emerging companies. By focusing on those with solid financials and growth potential, investors can uncover opportunities for both stability and upside in this unique segment of the market.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qtrx/quanterix/news/village-farms-international-and-2-other-penny-stocks-worth-w","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-qtrx/quanterix/news/village-farms-international-and-2-other-penny-stocks-worth-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QTRX","MJ","VFF","YOLO","BK4121","BK4189","NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654694037","title":"Press Release: Novabridge Biosciences to Hold Annual General Meeting on September 8, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654694037","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654694037?lang=en_us&edition=fundamental","pubTime":"2026-07-25 05:00","pubTimestamp":1784926800,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (\"NovaBridge\" or the \"Company\"), a clinical-stage biopharmaceutical company advancing innovative medicines for ar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652044324","title":"Novabridge Biosciences Launches 2026 Omnibus Share Incentive Plan with 11,960,000 Shares Authorized","url":"https://stock-news.laohu8.com/highlight/detail?id=2652044324","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652044324?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:05","pubTimestamp":1784282711,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences launches 2026 omnibus share incentive plan with 11,960,000 shares authorizedNovaBridge Biosciences adopted a 2026 Omnibus Share Incentive Plan effective July 13, 2026, replacing","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL1tMdJX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650134777","title":"Poland’s central bank is buying the dip as gold's biggest buyers aren't backing down","url":"https://stock-news.laohu8.com/highlight/detail?id=2650134777","media":"Kitco","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650134777?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:05","pubTimestamp":1783677900,"startTime":"0","endTime":"0","summary":"(Kitco News) - While speculators and retail investors have been liquidating their gold holdings, one major pillar of support remains firmly in place, with central banks viewing the current price actio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"kitco_highlight","url":"https://www.kitco.com/news/article/2026-07-10/polands-central-bank-buying-dip-golds-biggest-buyers-arent-backing-down","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.kitco.com/news/article/2026-07-10/polands-central-bank-buying-dip-golds-biggest-buyers-arent-backing-down","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"kitco_highlight","symbols":["GLDM","BGLD","IAU","GBUG","IAUM","JNUG","UGL","BTGD","PICK","BK4504","DUST","DULL","GOAU","GDXU","PPI","NBP","DBC","JDST","RING","BEGS","GOLY","GLDY","GDXJ","KGLD","GLL","AAAU","UYM","IGLD","IAUI","YGLD","DZZ","GDX","DGP","XME","BAR","GDXD","1OZmain","OUNZ","GLD","SGOL","FGDL","PHYS","USG","SHNY","GDXY","BK4588","CEF","DGZ","GLTR","SGDM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650915054","title":"Novabridge Biosciences CEO, Director Srishti Gupta Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2650915054","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650915054?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:25","pubTimestamp":1783542307,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences CEO, director Srishti Gupta files initial beneficial ownership statementNovaBridge Biosciences filed a Form 3 naming Srishti Gupta as chief executive officer, disclosing her ini","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDLb3rm1Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649553169","title":"Novabridge Biosciences SVP Clinical Development Xu Cong Claire Sells USD 3,991 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2649553169","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649553169?lang=en_us&edition=fundamental","pubTime":"2026-07-08 07:51","pubTimestamp":1783468265,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences SVP Clinical Development Xu Cong Claire sells USD 3,991 common sharesNovaBridge Biosciences SVP, Clinical Development Xu Cong Claire reported a net reduction in ordinary share h","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLSnybl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Novabridge Biosciences SVP Clinical Development Xu Cong Claire Sells USD 3,991 Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647759583","title":"Novabridge Biosciences Appoints DR. Srishti Gupta as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2647759583","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647759583?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA1ZJJRB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","IVVD","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647751383","title":"Novabridge Biosciences - Xi-yong (sean) Fu to Step Down as CEO and Support in Advisory Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2647751383","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647751383?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA1ZJJRB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647756733","title":"Press Release: Novabridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2647756733","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647756733?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730800,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (\"NovaBridge\" or the \"Company\"), a clinical-stage biopharmaceutical company advancing innovative medicines for ar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Novabridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646035396","title":"Wuxi XDC Appoints Yuan Fang Joint Company Secretary, Authorized Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=2646035396","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646035396?lang=en_us&edition=fundamental","pubTime":"2026-06-26 17:26","pubTimestamp":1782466014,"startTime":"0","endTime":"0","summary":"WuXi XDC appoints Yuan Fang joint company secretary, authorized representativeWuXi XDC named Yuan Fang joint company secretary, effective June 26, 2026; she also becomes an authorized representative.F","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL6Y0xcy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","BK4139","LU3063872942.SGD","LU0516422366.SGD","02269","LU1242518857.USD","LU0417516902.SGD","LU0348825331.USD","LU0140636845.USD","02268","BK1587","LU0823426480.USD","BK1589","LU0417516738.SGD","LU0348735423.USD","LU0051755006.USD","LU0327786744.USD","BK1161","LU0516423091.SGD","LU0320764599.SGD","LU0588546209.SGD","LU0359202008.SGD","LU0572944931.SGD","LU0039217434.USD","BK1574","LU0819121731.USD","LU0052750758.USD","LU1880383366.USD","LU0043850808.USD","LU1688375341.USD","LU0307460666.USD","LU1242518931.SGD","LU0181495838.USD","LU0456827905.SGD","LU1720050803.USD","LU2488822045.USD","LU0516422952.EUR","LU0979878070.USD","02137","LU0516423174.USD","BK1610","IE00B0JY6N72.USD","NBP","BK1141","SG9999002463.SGD","LU1794554557.SGD","LU0708995583.HKD","LU2039709279.SGD","LU0456846285.SGD","LU0516422440.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645900894","title":"NovaBridge Biosciences CMO Dennis Phillip Andrew disposes of ordinary shares worth $5,606.04","url":"https://stock-news.laohu8.com/highlight/detail?id=2645900894","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645900894?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:24","pubTimestamp":1782163461,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences Chief Medical Officer Dennis Phillip Andrew sold 8,494 ordinary shares on June 18 at USD 0.66.Holdings fell to 157,941 ordinary shares following the sale.Andrew also acquired 23,695 ordinary shares on June 17 via an equity award transaction.He reported 82,422 restricted share units after the June 17 vesting-related transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLbMrgn7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NovaBridge Biosciences CMO Dennis Phillip Andrew disposes of ordinary shares worth $5,606.04","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760741","title":"NovaBridge Biosciences replaces PwC with Deloitte as auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760741","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644760741?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:40","pubTimestamp":1781642455,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences replaced PwC as independent auditor with Deloitte, effective June 16, 2026, for the fiscal year ending Dec. 31, 2026.PwC audit opinions for fiscal 2025 and 2024 were clean, with no adverse opinion, disclaimer, or scope or accounting qualifications.No reported auditor disagreements; the only cited reportable issue was material weaknesses in IT general controls at Dec. 31, 2025 and 2024.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL4jzk5k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":74,"code":"91000000","status":"200"}]}}